Video-on-Demand Library


Collection
Keyword or phrase

Topic

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Tara Symonds (Clinical Outcome Solutions)

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Melanie Calvert (Birmingham University)

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Ingolf Griebsch (Boehringer-Ingelheim)

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Kim Cocks (Adelphi Values)

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Helen Doll (Clinical Outcome Solutions)

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Christoph Schürmann (IQWiG)

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

Q&A

23 August 2019

Chair: Rachael Lawrence

Part of Collection(s)

Topic(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

23 August 2019

Read more...

Patient reported outcomes have become increasingly important in the development, approval and reimbursement of our products. The PSI Scientific Committee have put together this one day meeting to provide statisticians with introductions to PROs, how to include them in clinical trials, considerations about missing data, appropriate statistical methods to analyse and interpret the data and the perspective of an IQWiG assessor. Presenters will give their insight into discussions with colleagues, working groups and regulators and there will be plenty of opportunity to ask any questions you may have about PROs in your development program. 

Related Videos

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

Part of Collection(s)


This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

31 July 2019

Read more...

In September 2018 the FDA published a guidance on adaptive design for clinical trials of drugs and biologics, updating (not finalizing) its initial draft from February 2010.  The main focus of the webinar is to provide an overview of its main contents, which is presented by Jürgen Hummel (PPD). In addition, Kaspar Rufibach (Roche) introduces an open-source statistical software for adaptive designs, RPACT (an R package that enables the design and analysis of confirmatory adaptive clinical trials).  Kit Roes also comments on the guidance from a European Regulatory perspective.

14 July 2019

Join us in our discussion on survival analysis method with focus on the application of two Bayesian methods for time to event data at 4pm (BST) on Thursday 11 July.Our two presenters are Peter Thall from MD Anderson and Kyu Ha Lee from Harvard. The discussants are: Axel Gandy, Imperial College London (RSS discussant) and Neby Bekele, Gilead Sciences (PSI discussant).

Read more...

 

Topic(s)


Page: